Abstract
Background:Glucocorticoids are commonly used to control musculoskeletal or skin symptoms of patients with early diffuse systemic sclerosis (SSc), but there is limited evidence supporting their effectiveness on skin fibrosis [1]....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
